Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
F | Common Stock | D | 2647 | $19.99 - $19.99 | $52,913 |
| 2024-09-30 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
F | Common Stock | D | 21752 | $19.99 - $19.99 | $434,822 |
| 2024-09-09 | ADMA BIOLOGICS, INC. | Guiheen Lawrence P.
(Director) |
S | Common Stock | D | 9000 | $18.47 - $18.47 | $166,188 |
| 2024-09-09 | ADMA BIOLOGICS, INC. | Guiheen Lawrence P.
(Director) |
M | Common Stock | A | 9000 | $10.80 - $10.80 | $97,200 |
| 2024-08-30 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
S | Common Stock | D | 24150 | $16.90 - $16.90 | $408,050 |
| 2024-08-30 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
M | Common Stock | A | 24150 | $2.35 - $5.94 | $93,525 |
| 2024-08-29 | ADMA BIOLOGICS, INC. | Grossman Jerrold B
(Director) |
S | Common Stock | D | 136861 | $17.27 - $17.27 | $2,363,931 |
| 2024-08-29 | ADMA BIOLOGICS, INC. | Grossman Jerrold B
(Director) |
M | Common Stock | A | 136861 | $3.66 - $10.80 | $585,871 |
| 2024-08-26 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
S | Common Stock | D | 626245 | $17.29 - $17.69 | $10,923,986 |
| 2024-08-26 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
M | Common Stock | A | 626245 | $2.92 - $10.80 | $2,903,189 |
| 2024-08-23 | ADMA BIOLOGICS, INC. | KWON YOUNG
(Director) |
S | Common Stock | D | 60000 | $18.26 - $18.26 | $1,095,600 |
| 2024-07-24 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
F | Common Stock | D | 2502 | $13.58 - $13.58 | $33,977 |
| 2024-07-24 | ADMA BIOLOGICS, INC. | Tade Brad L.
(CFO and Treasurer) |
A | Common Stock | A | 72400 | $0.00 - $0.00 | $0 |
| 2024-06-30 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
F | Common Stock | D | 2085 | $11.18 - $11.18 | $23,310 |
| 2024-06-30 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President,CEO, and Interim CFO) |
F | Common Stock | D | 21752 | $11.18 - $11.18 | $243,187 |
| 2024-06-14 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President,CEO, and Interim CFO) |
S | Common Stock | D | 100000 | $10.72 - $10.72 | $1,071,980 |
| 2024-06-14 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President,CEO, and Interim CFO) |
J | Common Stock | D | 460000 | $3.21 - $3.21 | $1,476,600 |
| 2024-06-14 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President,CEO, and Interim CFO) |
G | Common Stock | D | 10000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |